Centro Médico Teknon
Centro Médico Teknon
Spain, Barcelona
Francesc Cobo Valien
27 years of experience
Clinic is certified :
Lymphoma chemotherapy in Spain typically costs from $5,000 to $9,000. The final price depends on the specific protocol used, number of cycles, and clinic location. In the US, similar procedures cost around $22,500 on average. Patients can achieve savings of around 69%. These prices often cover the chemotherapy drugs, medical fees, and essential blood monitoring.
Bookimed Expert Insight: Choosing a multi-center network like Quironsalud Madrid or HM Madrid offers a strategic advantage. These institutions frequently provide access to clinical trials. This can sometimes provide cutting-edge treatments at significantly reduced costs. For example, Centro Médico Teknon is accredited by JCI and treated world-famous athletes. This suggests that even their mid-range pricing includes 5-star quality and high-tech equipment.
Why choose Spain for lymphoma chemotherapy?
Access advanced Lymphoma chemotherapy solutions in trusted clinics .
| Turkey | Austria | Spain | |
| Lymphoma chemotherapy | from $3,000 | from $8,000 | from $5,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Lymphoma chemotherapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Lymphoma chemotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Lymphoma chemotherapy journey.
Day 1
Day 2
Day 3-4
Day 5
Week 2-6
Week 7 onwards
Please note that the above timeline is a general guideline and individual cases may vary.
Dr. Cobo Valien specializes in lymphoma treatment with a strong research background, including grants from the Generalitat de Catalunya and the Catalan Society of Hematology.
Leading expert in chronic lymphocytic leukemia – Professor Bosch develops new treatments through over 80 active clinical trials.
Leads the Hematology & Pediatric Oncology Unit at HM Hospitales – a top expert in pediatric lymphoma care with 31 years of experience of experience.
32 years of experience focusing on pediatric hematology and oncology – Dr. Lopez Ibor leads the Pediatric Hematology and Oncology Unit at HM Montepríncipe.
To ensure optimal care with a Spanish hematologist, ask about the specific therapeutic goals, the integration of advanced techniques like CAR T-cell therapy, and the hospital 24/7 emergency protocols. Focus on clarifying the cycle schedule within the Hospital de Día and access to JCI-accredited oncology support.
Bookimed Expert Insight: Spain is a global leader in hematology, with specialists like Dr. Francesc Bosch managing over 80 clinical trials. When choosing a clinic, check for academic leadership. Centers like Centro Médico Teknon or Ruber Internacional often provide access to experimental therapies—such as specialized CAR T-cell protocols—that are not yet standard in common community hospitals.
Patient Consensus: Patients emphasize asking for prophylactic growth factors like Filgrastim early to prevent low white blood cell counts. Success often depends on keeping a detailed symptom log to help doctors adjust dosages during the quiet weeks between cycles.
Finding a lymphoma specialist in Spain involves targeting JCI-accredited oncology centers in Madrid and Barcelona. Direct access is available through private medical platforms, which connect patients with hematologists specializing in CAR T-cell therapy, bone marrow transplantation, and advanced chemotherapy protocols for Hodgkin and Non-Hodgkin cases.
Bookimed Expert Insight: Spain’s oncology market is highly concentrated, with a few elite experts holding massive clinical trial portfolios. For instance, Dr. Francesc Bosch at Quironsalud Barcelona oversees 80+ trials, offering patients access to emerging therapies not yet standard elsewhere. This makes Spain particularly strong for patients who have not responded to frontline treatments.
Patient Consensus: Patients emphasize the importance of choosing a dedicated cancer center over a general clinic for complex lymphoma protocols. Success often depends on quick biopsy-to-treatment timelines, which are typically under 2 months in Spain's private sector.
Spain is a global leader in providing advanced CAR T-cell therapy for blood cancers, including lymphoma and leukemia. The country offers both commercial products and unique authorized academic versions. Treatment is available at 28 accredited centers, including Joint Commission International (JCI)-accredited facilities in Barcelona and Madrid.
Bookimed Expert Insight: Spain is a strategic choice for lymphoma patients due to its academic `Hospital Exemption` programs. Data shows clinics like Quironsalud Madrid offer access to treatments through clinical trials. This innovation allows patients to access advanced therapies that are often significantly more affordable than commercial products.
Patient Consensus: Patients report that Barcelona is a top destination for CD30-targeted CAR-T therapy with short waiting lists. Many find Spain a cost-effective alternative to the US, noting high remission rates in clinical trial cohorts.
Hematologists in Spain evaluate chemotherapy success through high-frequency blood analysis and selective imaging. Doctors prioritize monitoring lactate dehydrogenase (LDH) levels, liver function, and complete blood counts. Advanced centers like Centro Medico Teknon also use PET-CT scans to assess metabolic activity in residual lymphoma cells after two to four cycles.
Bookimed Expert Insight: Spanish hematologists frequently lead large-scale research, such as Dr. Francesc Bosch at Hospital Quiron Barcelona who manages over 80 clinical trials. This research focus means patients often access the latest molecular monitoring techniques, like ctDNA tracking, sooner than in many private clinics elsewhere in Europe.
Patient Consensus: Patients should expect frequent blood tests at days 1, 3, and 7 during intensive cycles like BEACOPP. Routine scans are often minimized for those in remission to avoid unnecessary radiation exposure.
Spain hosts world-class lymphoma centers like Centro Médico Teknon and Hospital Quirónsalud Barcelona, renowned for advanced oncohematology. These JCI-accredited facilities offer innovative CAR T-cell therapy, bone marrow transplants, and biological therapies. Specialist doctors manage high-profile clinical trials, ensuring access to the latest hematological drugs.
Bookimed Expert Insight: Lymphoma patients in Spain benefit from a high density of clinical trials. Dr. Francesc Bosch at Quirónsalud alone manages over 80 trials. This provides unique access to experimental drugs often unavailable elsewhere. Choosing a trial-active center significantly increases options for complex or resistant lymphoma cases.
Patient Consensus: Treatment usually begins within 2 months of diagnosis. Patients advise confirming if specific regimens like A+AVD are available and emphasize building strong bonds with the attentive medical staff.
Spain offers several advanced medical additions and alternatives to traditional chemotherapy, including CAR T-cell therapy, targeted immunotherapy, and stem cell transplantation. Leading facilities like Centro Médico Teknon and Hospital Ruber Internacional utilize these precise biological treatments to enhance standard R-CHOP or ABVD protocols for lymphoma patients.
Bookimed Expert Insight: While chemotherapy remains the primary tool, Spanish research centers provide unique access to clinical trials for relapsed lymphoma. Clinics like Quironsalud Madrid sometimes offer these innovative treatments at no cost to eligible patients. Choosing a facility with a Laboratory for Molecular Medicine, such as SJD Barcelona, ensures your treatment plan is mapped to your specific genetic markers.
Patient Consensus: Patients emphasize that standard chemotherapy remains the most effective first-line defense. They advise seeking second opinions at specialized centers to explore how immunotherapy can be safely added to their regimen.
Active monitoring is a standard and common practice for managing slow-growing, indolent lymphomas in Spain. Spanish oncologists utilize this strategy for asymptomatic patients to delay chemotherapy side effects, as immediate treatment for these cases has not shown a long-term survival advantage.
Bookimed Expert Insight: While many expect immediate action, Spain’s high global rank for oncology is built on precisely following these surveillance protocols. At JCI-accredited centers like Centro Médico Teknon or Ruber Internacional, patients benefit from 3-Tesla MRI and PET imaging to track minimal changes. This high-resolution monitoring allows experts like Dr. Francesc Cobo Valien to safely manage patients for years before starting chemo, which costs between $5,000 and $9,000 when eventually required.
Patient Consensus: Many patients find success by viewing lymphoma as a chronic condition rather than an emergency. Those who feel physically normal often prefer regular checkups over the immediate impact of side effects.